India to Australia: Lenalidomide Export Trade Route
India has recorded 11 verified shipments of Lenalidomide exported to Australia, representing a combined trade value of $1.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $95.8K USD. The leading Indian exporter is CIPLA LIMITED , which accounts for 100% of total export value with 10 shipments worth $1.0M USD. On the buying side, CIPLA AUSTRALIA PTY LTD is the largest importer in Australia with $1.0M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Lenalidomide corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $1.1M USD. The route is dominated by CIPLA LIMITED , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $95.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 28.0%, placing it at rank #10 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in Australia include CIPLA AUSTRALIA PTY LTD , XXlanXXrelXXd LXXiteXX NeXXnhaXXCouXX MXXahiXX Ro. CIPLA AUSTRALIA PTY LTD is the single largest importer with 10 shipments valued at $1.0M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#10
- Annual growth+28.0%
- Demand growth+25.3%
- Regulatory ease70/100
Top 10 Indian Lenalidomide Exporters to Australia
Showing top 10 of 2 Indian suppliers exporting Lenalidomide to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $104.9K per shipment | 10 | $1.0M | 99.5% |
| 2 | MYLAN LABORATORIES LIMITED Avg $5.2K per shipment | 1 | $5.2K | 0.5% |
This table shows the top 10 of 2 Indian companies exporting lenalidomide to Australia, ranked by total trade value. The listed exporters are: CIPLA LIMITED , MYLAN LABORATORIES LIMITED. CIPLA LIMITED is the dominant supplier with 10 shipments worth $1.0M USD, giving it a 100% market share.
Top 10 Lenalidomide Importers in Australia
Showing top 10 of 2 known buyers in Australia receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in Australia include CIPLA AUSTRALIA PTY LTD , XXlanXXrelXXd LXXiteXX NeXXnhaXXCouXX MXXahiXX Ro. The largest importer is CIPLA AUSTRALIA PTY LTD , accounting for $1.0M USD across 10 shipments — representing 100% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA AUSTRALIA PTY LTD | 10 | $1.0M | 99.5% |
| 2 | XXlanXXrelXXd LXXiteXX NeXXnhaXXCouXX MXXahiXX Ro | 1 | $5.2K | 0.5% |
Top 10 Lenalidomide Formulations Imported by Australia
Showing top 10 of 5 product formulations shipped on the India to Australia Lenalidomide route, ranked by trade value
Australia imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CIPLA LENALIDOMIDE 10MG CAPSULES (LENALI — accounts for $464.3K USD across 3 shipments. A total of 5 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LENALIDOMIDE 10MG CAPSULES (LENALI | 3 | $464.3K | 44.1% |
| 2 | CIPLA LENALIDOMIDE 15MG CAPSULES (LENALI | 3 | $299.7K | 28.4% |
| 3 | CIPLA LENALIDOMIDE 5MG CAPSULES (LENALID | 2 | $150.7K | 14.3% |
| 4 | CIPLA LENALIDOMIDE 25MG CAPSULES (LENALI | 2 | $134.1K | 12.7% |
| 5 | LENALIDOMIDE CAP 15MG 21BL AU VIA | 1 | $5.2K | 0.5% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 10 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's lenalidomide exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED , MYLAN LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $95.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as cipla lenalidomide 15mg capsules (lenali and cipla lenalidomide 5mg capsules (lenalid , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA AUSTRALIA PTY LTD is the largest importer with 10 shipments worth $1.0M USD — representing 100% of all lenalidomide imports from India on this route.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $95.8K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~34 days
- Annual Growth
- +28.0%
Related Analysis
Other Lenalidomide Routes
Unlock the Full India to Australia Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Australia Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to Australia?
The leading Indian exporters of Lenalidomide to Australia are CIPLA LIMITED , MYLAN LABORATORIES LIMITED. CIPLA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to Australia?
India exports Lenalidomide to Australia worth approximately $1.1M USD across 11 recorded shipments. The average value per shipment is $95.8K USD.
Q Which ports does India use to ship Lenalidomide to Australia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 10 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Australia for Lenalidomide?
The average transit time for Lenalidomide shipments from India to Australia is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Australia Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.0% with demand growth tracking at 25.3%. The route is ranked #10 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to Australia Lenalidomide route?
There are currently 2 active Indian suppliers exporting Lenalidomide to Australia. The market is moderately concentrated with CIPLA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Lenalidomide from India in Australia?
The leading importers of Indian Lenalidomide in Australia include CIPLA AUSTRALIA PTY LTD , XXlanXXrelXXd LXXiteXX NeXXnhaXXCouXX MXXahiXX Ro. CIPLA AUSTRALIA PTY LTD is the largest buyer with 10 shipments worth $1.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists